Harry Mansbach

Harry Mansbach

Chief Tech/Sci/R&D Officer at 89BIO, INC.
61 year
Health Technology
Consumer Services
Health Services

Profile

Harry H.
Mansbach
currently works at 89bio, Inc., as Chief Medical Officer from 2018.
Dr. Mansbach also formerly worked at GlaxoSmithKline LLC, as Director-Clinical Development & Neurosciences, Bausch Health Americas, Inc., as Senior VP & Head-Global Drug Development, RespireRx Pharmaceuticals, Inc., as Chief Medical Officer & VP-Clinical Development from 2004 to 2006, Ultragenyx Pharmaceutical, Inc., as Head-Global Clinical Development in 2018, Henry Ford Health System, as Member-Neurology Department, and Medivation LLC (California), as Vice President-Medical Affairs from 2009 to 2015.
Dr. Mansbach received his doctorate degree from Duke University and undergraduate degree from Yale University.

Harry Mansbach active positions

CompaniesPositionStart
89BIO, INC. Chief Tech/Sci/R&D Officer 01/12/2018

Former positions of Harry Mansbach

CompaniesPositionEnd
ULTRAGENYX PHARMACEUTICAL INC. Chief Tech/Sci/R&D Officer 01/12/2018
MEDIVATION INC Chief Tech/Sci/R&D Officer 01/04/2015
RESPIRERX PHARMACEUTICALS INC. Chief Tech/Sci/R&D Officer 15/12/2006
Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
See the detail of Harry Mansbach's experience

Training of Harry Mansbach

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Harry Mansbach